Inventor · disambiguated record
Balázs Sümegi
Also filed as: SUEMEGI BALAZS · SUEMEGI BALáZS · SUMEGI BALAZS · Sümegi Balázs
12 granted patents·5 pending applications·137 citations·filing 1996–2016
91Inventor score
Files withN GENE RES LAB INC11CEDARS SINAI MEDICAL CENTER1GENE RES LABORATIORIES INC N1Gallyas Ferenc 1N-GENE RESEARCH LAB INC1
Top patents by PatentIndex Score
17 records- 0193US6838469B2Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activityN GENE RES LAB INC·Filed 2002·Granted Jan 4, 2005·56 cites·12 claims
- 0278US6656955B2Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivativeN GENE RES LAB INC·Filed 2002·Granted Dec 2, 2003·10 cites·12 claims
- 0376US6720337B2Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivativeN GENE RES LAB INC·Filed 2002·Granted Apr 13, 2004·8 cites·6 claims
- 0472US6887872B2Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the sameGENE RES LABORATIORIES INC N·Filed 2001·Granted May 3, 2005·10 cites·7 claims
- 0571US7151175B2Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the sameN GENE RES LAB INC·Filed 2005·Granted Dec 19, 2006·1 cites·4 claims
- 0669US7763601B2Prevention and treatment of obesityN GENE RES LAB INC·Filed 2007·Granted Jul 27, 2010·2 cites·3 claims
- 0756US6440998B1Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivativeN GENE RES LAB INC·Filed 1998·Granted Aug 27, 2002·10 cites·10 claims
- 0854US7994182B2Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effectPECSI TUDOMANYEGYETEM·Filed 2004·Granted Aug 9, 2011·1 cites·9 claims
- 0952US6306878B1Pharmaceutical compositions containing hydroximic acid derivativesN-GENE RESEARCH LAB INC·Filed 1996·Granted Oct 23, 2001·16 cites·7 claims
- 1052US2008108602A1Prevention of obesity in antipsychotic, antidepressant and antiepileptic medicationN GENE RES LAB INC·Filed 2007·Application pending·0 cites
- 1150US6451851B1Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agentN GENE RES LAB INC·Filed 1998·Granted Sep 17, 2002·14 cites·7 claims
- 1249US6500823B1Unsaturated hydroximic acid derivatives as per abstract inhibitorsN GENE RES LAB INC·Filed 1999·Granted Dec 31, 2002·9 cites·25 claims
- 1343US2010311719A1Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic MedicationN GENE RES LAB INC·Filed 2010·Application pending·0 cites
- 1441US2015366852A1Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic MedicationN GENE RES LAB INC·Filed 2015·Application pending·0 cites
- 1537US2007072912A1Alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidantsCEDARS SINAI MEDICAL CENTER·Filed 2004·Application pending·0 cites
- 1633US2011098255A1Combination of a parp inhibitor and an akt kinase activating compoundGallyas Ferenc ·Filed 2009·Application pending·0 cites
- 1724US9884040B2Desethylamiodarone for use in cancer treatmentPECSI TUDOMÁNYEGYETEM·Filed 2016·Granted Feb 6, 2018·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →